Commitment to Action

Improving Maternal and Perinatal Health: Odon Device

Commitment by

Becton, Dickinson and Company

In 2013, Becton, Dickinson & Co. (BD) committed to, at the request of the World Health Organization (WHO), invest in R&D, manufacturing and global distribution of the Odon Device, a new obstetrical device designed to replace forceps or vacuum-assist devices, which are known to cause injury in circumstances of prolonged labor. Obstructed or prolonged labors occur in approximately 10 percent of all births and are common causes of maternal and child mortality, particularly in less developed countries where 99 percent of these mortalities happen. Each day, approximately 1,000 women die in childbirth, and 20 times more experience serious medical complications such as bleeding, infection and fistula. WHO is conducting the clinical studies for the Odon Device, and partners in the Grand Challenge for Saving Lives at Birth are committing further support. The Odon Device will be developed at BD's R&D center in Singapore and the company will offer access pricing in developing countries.

Share

Tabs

Overview
Summary

Commitment

Improving Maternal and Perinatal Health: Odon Device

Launched

2013

Est. Duration

5 years

Estimated Total Value

$20,000,000

Region

Latin America & Caribbean, Asia, Africa

Countries

ARGENTINA, BANGLADESH, BRAZIL, BURKINA FASO, CAMBODIA, CAMEROON, CHINA, COLOMBIA, COTE D'IVOIRE, Democratic Republic of the Congo

Commitment by

Becton, Dickinson and Company

Partner(s) of the Commitment Maker(s)

United States Agency for International Development, Saving Lives at Birth, Jorge Odon, World Health Organization, Bill & Melinda Gates Foundation, The Partnership for Maternal, Newborn and Child Health, Grand Challenges Canada, Economic Development Board Singapore